Lexicon Pharmaceuticals
LXRX
LXRX
101 hedge funds and large institutions have $251M invested in Lexicon Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 33 increasing their positions, 39 reducing their positions, and 16 closing their positions.
Holders
101
Holders Change
-9
Holders Change %
-8.18%
% of All Funds
1.6%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
33
Reduced
39
Closed
16
Calls
$169K
Puts
$65K
Net Calls
+$104K
Net Calls Change
+$366K
Top Buyers
1 |
1
D.E. Shaw & Co
New York
|
$6.75M |
2 |
2
Citadel Advisors
Miami,
Florida
|
$945K |
3 |
3
Walleye Capital
New York
|
$420K |
4 |
GCP
4
GSA Capital Partners
London,
United Kingdom
|
$482K |
5 |
5
Fisher Asset Management
Camas,
Washington
|
$770K |